Biomarkers Predicting Response to Radiotherapy and Radium-223 in Bone Metastatic Prostate Cancer: ADRRAD Trial Findings
Larvol Clinic
Command Palette
Search for a command to run...
Archive
303 posts published so far
Phase I Study of BAT1306 and BAT8001 in HER2-Positive Advanced Solid Tumors: Safety, Tolerability, and Dose Evaluation
Larvol Clinic
Association of Blood Tumor Mutational Burden with Pembrolizumab Efficacy in KEYNOTE-189
Larvol Clinic
Phase 1b Trial of Alofanib (RPT835) in Advanced Gastric Adenocarcinoma: Safety, Tolerability, and Preliminary Efficacy
Larvol Clinic
Role of CCL2-CCR2 Axis Signaling in the Progression of Diffuse Large B Cell Lymphoma: Implications for Targeted Therapy
Larvol Clinic
Phase I Clinical Trial Evaluating Safety, Tolerability, and Efficacy of BAT1306 and BAT8001 in Patients with HER2-Positive Advanced Solid Tumors
Larvol Clinic
Phase I/II Study of Monoclonal Antibody Therapy and Interleukin-2 in the Treatment of Leukemia and Lymphoma
Larvol Clinic
Safety and Efficacy of pTVG-HP Vaccine Combined with Nivolumab in Early, Recurrent Prostate Cancer
Larvol Clinic
Study on Non-Inferiority of ESP vs. PVB for Pain Management in Unilateral Mastectomy with Immediate Reconstruction
Larvol Clinic
Evaluating Axitinib-Pembrolizumab for RCC: Advancing Treatment Strategies and Remote Monitoring via Web-Application
Larvol Clinic
Phase 1b/3 Study of IBI351 and Cetuximab for KRAS G12C-Mutated Metastatic Colorectal Cancer
Larvol Clinic
Study on Vaccination Safety and Immune Response in Children with KHE During Sirolimus Therapy
Larvol Clinic
Prospective Biomarker Study on Prognostic Impact of ctDNA in Ewing Sarcoma and Osteosarcoma
Larvol Clinic
Phase II Study of Epcoritamab-Based Consolidation After CAR T-Cell Therapy for High-Risk Large B-Cell Lymphoma
Larvol Clinic
Phase II Study of ZK 219477 for Safety and Efficacy in Metastatic Breast Cancer
Larvol Clinic
Phase I/II Study of Liposomal Daunorubicin and SU5416 for Resistant Hematologic Cancers
Larvol Clinic
Phase I/II Study of Liposomal Daunorubicin and SU5416 for Resistant Hematologic Cancers
Larvol Clinic
Thalidomide and Dexamethasone as Maintenance Therapy After Stem Cell Transplant in Multiple Myeloma
Larvol Clinic
Phase I Study of CBM588 with Nivolumab and Ipilimumab for Advanced Kidney Cancer
Larvol Clinic
Impact of IDH2 Variants and Co-Mutations on Survival in Relapsed/Refractory AML
Larvol Clinic
Olaparib Addition to Carboplatin-Paclitaxel in Triple-Negative Breast Cancer: No Benefit in pCR or Survival
Larvol Clinic
Daratumumab Enhances VCD Therapy in Transplant-Ineligible Myeloma: Improved PFS and Response Rates
Larvol Clinic
Sequential Dosing of Sacituzumab Govitecan and Talazoparib in Metastatic Triple-Negative Breast Cancer: Feasibility and Efficacy
Larvol Clinic
Real-World Effectiveness of Avelumab in Advanced Urothelial Carcinoma: J-AVENUE Study Results
Larvol Clinic
Ovarian Toxicity in Females with Desmoid Tumors Treated with Nirogacestat: Insights from the Phase 3 DeFi Study
Larvol Clinic